SCM
NMTC icon

Sio Capital Management’s NeuroOne Medical Technologies NMTC Stock Holding History

Sio Capital Management’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$386K Sell
82,769
-107,238
-56% -$515K 0.06% 67
2025
Q4 		$864K Sell
190,007
-203,432
-52% -$927K 0.14% 57
2025
Q3 		$2.1M Sell
393,439
-193,838
-33% -$949K 0.53% 36
2025
Q2 		$2.39M Buy
+587,277
New +$2.17M 0.91% 30

Other funds holding NMTC

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sio Capital Management's NMTC Position: Q1 2026 in Review

Sio Capital Management reduced its NeuroOne Medical Technologies (NMTC) stake by 56% in Q1 2026, selling an estimated $515K and leaving 82,769 shares worth $386K. The position accounts for 0.06% of the portfolio, ranked #67.

Sio Capital Management first reported a position in NMTC in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.39M in Q2 2025. 32 funds tracked by Wall St. Rank hold NMTC as of Q1 2026.

  • Sio Capital Management held 82,769 shares of NeuroOne Medical Technologies worth $386K as of Q1 2026.
  • Sio Capital Management sold 107,238 NeuroOne Medical Technologies shares in Q1 2026, an estimated $515K.
  • NeuroOne Medical Technologies made up 0.06% of Sio Capital Management's portfolio in Q1 2026, its #67 holding.
  • Sio Capital Management first reported a position in NeuroOne Medical Technologies in Q2 2025 and has held it in 4 quarters since.
  • Sio Capital Management's NeuroOne Medical Technologies position peaked at $2.39M in Q2 2025.
  • 32 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q1 2026.

Based on Sio Capital Management's 13F filing for Q1 2026, filed 14 May 2026.